ADC Therapeutics regains NYSE minimum bid price compliance; removed from noncompliant list

ADC Therapeutics SA

Received NYSE notice on Jan 2, 2024 confirming compliance with Section 802.01C.
Cure: closing price on Dec 29, 2023 and 30-trading-day average both above $1.00.
Previously noncompliant due to average closing price below $1.00 over 30 days.
Company will be removed from NYSE's noncompliant issuers list.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.